Abramson Cancer Center's Pancreatic Research Center, led by Dr. Ben Stranger, is revolutionizing the way this disease is treated. Learn more about pancreatic cancer clinical trials at Penn and why there is now hope for all stages.

Dr. Aggarwal and the rest of the team at Penn are transforming the way lung cancer is treated. Learn more about their research and how new drugs are helping patients.

Looking at a tumor’s genetic information can provide a clearer picture of a patient’s unique condition and how to best treat it.

Danielle’s genetic testing journey changed her life. Read how she’s taken charge of her health to get ahead of her family’s history of pancreatic cancer.

Medical oncologist Dr. Mark H. O’Hara explains how research on innovative immunotherapy therapies at Penn may offer hope to current and future pancreatic cancer patients.

With advancements in immunotherapy, radiation therapy and surgical resection, Penn Medicine is making progress towards a life-extending treatment for the aggressive brain cancer, glioblastoma.

Learn how Penn is evaluating those at risk for pancreatic cancer and working every day to bring more treatments - and hope - to those diagnosed with this devastating disease.

Hematology oncologist Dr. Yehoda Martei is in Botswana, treating people with and conducting research on breast cancer. Here, she offers a perspective on the issues.

Penn Medicine is researching immunotherapy as a promising new treatment for those diagnosed with triple negative breast cancer.

Penn's Abramson Cancer Center is leading a clinical trial to determine which type of radiation—proton or photon—will help women with breast cancer reduce heart risks.